David Hirsch - 16 Jun 2021 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Role
Director
Signature
/s/ Johanna M. Mylet, Attorney-in-Fact
Issuer symbol
PSTX
Transactions as of
16 Jun 2021
Transactions value $
$0
Form type
4
Filing time
17 Jun 2021, 17:03:02 UTC
Previous filing
11 Jun 2021
Next filing
14 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PSTX Stock Option (Right to Buy) Award $0 +20K $0.00 20K 16 Jun 2021 Common Stock 20K $8.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest and become fully exercisable on the earlier to occur of (i) June 16, 2022 and (ii) the day preceding the date of the next annual meeting of the stockholders of the Issuer.